B Dislich, SF Lichtenthaler - Frontiers in physiology, 2012 - frontiersin.org
The β-site APP cleaving enzyme 1 (BACE1) is a transmembrane aspartyl protease involved in Alzheimer's disease (AD) pathogenesis and in myelination. BACE1 initiates the …
A Pišlar, J Kos - Molecular neurobiology, 2014 - Springer
Increased proteolytic activity is a hallmark of several pathological processes, including neurodegeneration. Increased expression and activity of cathepsins, lysosomal cysteine …
Á De Mingo, E De Gregorio, A Moles, N Tarrats… - Cell Death & …, 2016 - nature.com
Abstract Sirtuin-1 (SIRT1) regulates hepatic metabolism but its contribution to NF-κB- dependent inflammation has been overlooked. Cysteine cathepsins (Cathepsin B or S …
Cathepsins (CTSs) are ubiquitously expressed proteases normally found in the endolysosomal compartment where they mediate protein degradation and turnover …
L Cao, X Cao, Y Zhou, BV Nagpure, ZY Wu… - Brain, Behavior, and …, 2018 - Elsevier
Neuroinflammation and excessive β-amyloid 1–42 (Aβ 1–42) generation contribute to the pathogenesis of Alzheimer's disease (AD). Emerging evidence has demonstrated that …
B Ridolfi, H Abdel-Haq - Current gene therapy, 2017 - ingentaconnect.com
Neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, Huntington's disease and prion disease are not timely and …
R R. Desrosiers, I Fanelus - Current aging science, 2011 - benthamdirect.com
Proteins are susceptible to numerous non-enzymatic post-translational modifications which occur both during normal aging and in neurodegenerative states. For instance, formation of …
Y Wang, RG MacDonald, G Thinakaran, S Kar - Molecular neurobiology, 2017 - Springer
The insulin-like growth factor II/mannose 6-phosphate (IGF-II/M6P) receptor is a multifunctional single transmembrane glycoprotein. Recent studies have advanced our …
A Pišlar, L Bolčina, J Kos - Biomolecules, 2021 - mdpi.com
Neuroinflammation, which is mediated by microglia and astrocytes, is associated with the progression of neurodegenerative diseases. Increasing evidence shows that activated …